{"transactions":[{"id":864731,"issuer":{"id":1775,"kind":"organization","name":"Maze Therapeutics, Inc.","symbol":"MAZE"},"owners":[{"id":63118,"kind":"person","name":"Tahir Misbah","position":1,"cik":"0001787359","reported_name":"Tahir Misbah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-03T16:30:38.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock unit award shall vest in ratable increments of 1/4 of the total award, with the first tranche vesting on March 1, 2027, and vesting thereafter on the one year anniversary of such date, subject to the reporting person's continued service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date."}],"balance_after":20000,"derivative":{"underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001787359-26-000002","document":"form4-03032026_090333.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1787359/000178735926000002/form4-03032026_090333.xml","form_type":"4"}},{"id":864730,"issuer":{"id":1775,"kind":"organization","name":"Maze Therapeutics, Inc.","symbol":"MAZE"},"owners":[{"id":63118,"kind":"person","name":"Tahir Misbah","position":1,"cik":"0001787359","reported_name":"Tahir Misbah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-03T16:30:38.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award shall vest as to 1/48 of the total award monthly, with the first tranche vesting on April 1, 2026, subject to the reporting person's continued service to the Issuer on each vesting date."}],"balance_after":40000,"derivative":{"exercise_price":45.61,"expiration_date":"2036-03-01","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001787359-26-000002","document":"form4-03032026_090333.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787359/000178735926000002/form4-03032026_090333.xml","form_type":"4"}},{"id":1051109,"issuer":{"id":1775,"kind":"organization","name":"Maze Therapeutics, Inc.","symbol":"MAZE"},"owners":[{"id":63118,"kind":"person","name":"Tahir Misbah","position":1,"cik":"0001787359","reported_name":"Tahir Misbah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-09-02T18:30:50.000Z","date":"2025-09-02","kind":"grant","planned":false,"acquired":true,"shares":325000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest as to 1/4th of the total award on September 2, 2026, and thereafter shall vest as to 1/48th of the total award on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date."}],"balance_after":325000,"derivative":{"exercise_price":15.32,"expiration_date":"2035-09-01","underlying":"Common Stock","underlying_shares":325000},"source":{"system":"sec-edgar","filing":"0001415889-25-023463","document":"form4-09022025_100947.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787359/000141588925023463/form4-09022025_100947.xml","form_type":"4"}},{"id":1081390,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":63118,"kind":"person","name":"Tahir Misbah","position":1,"cik":"0001787359","reported_name":"Tahir Misbah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-07-25T19:06:03.000Z","date":"2025-07-23","kind":"sale","planned":false,"acquired":false,"shares":8741,"price":1.2728,"value":11125.5448,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $1.27 to $1.275.  The price reported above reflects the weighted average sale price.  The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer full information regarding the number of shares sold at each separate sale price."}],"balance_after":170061,"source":{"system":"sec-edgar","filing":"0001415889-25-020311","document":"form4-07252025_110759.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000141588925020311/form4-07252025_110759.xml","form_type":"4"}},{"id":1104983,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":63118,"kind":"person","name":"Tahir Misbah","position":1,"cik":"0001787359","reported_name":"Tahir Misbah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-06-20T20:23:02.000Z","date":"2025-06-16","kind":"sale","planned":false,"acquired":false,"shares":1522,"price":1.1992,"value":1825.1824,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $1.17 to $1.22.  The price reported above reflects the weighted average sale price.  The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer full information regarding the number of shares sold at each separate sale price."}],"balance_after":178802,"source":{"system":"sec-edgar","filing":"0001415889-25-017915","document":"form4-06212025_120658.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000141588925017915/form4-06212025_120658.xml","form_type":"4"}},{"id":1199684,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":63118,"kind":"person","name":"Tahir Misbah","position":1,"cik":"0001787359","reported_name":"Tahir Misbah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-03-18T19:09:16.000Z","date":"2025-03-14","kind":"sale","planned":false,"acquired":false,"shares":7329,"price":1.23,"value":9014.67,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $1.19 to $1.28.  The price reported above reflects the weighted average sale price.  The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer full information regarding the number of shares sold at each separate sale price."}],"balance_after":180324,"source":{"system":"sec-edgar","filing":"0001415889-25-008520","document":"form4-03182025_110312.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000141588925008520/form4-03182025_110312.xml","form_type":"4"}},{"id":1326632,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":63118,"kind":"person","name":"Tahir Misbah","position":1,"cik":"0001787359","reported_name":"Tahir Misbah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-12-18T19:10:18.000Z","date":"2024-12-16","kind":"sale","planned":false,"acquired":false,"shares":1708,"price":7.48,"value":12775.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $7.00 to $7.84.  The price reported above reflects the weighted average sale price.  The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer full information regarding the number of shares sold at each separate sale price."}],"balance_after":187653,"source":{"system":"sec-edgar","filing":"0001415889-24-029775","document":"form4-12192024_121215.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000141588924029775/form4-12192024_121215.xml","form_type":"4"}},{"id":1357162,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":63118,"kind":"person","name":"Tahir Misbah","position":1,"cik":"0001787359","reported_name":"Tahir Misbah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-11-20T17:36:29.000Z","date":"2024-11-18","kind":"grant","planned":false,"acquired":true,"shares":66667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. 50% of the RSUs shall vest on each of January 12, 2026 and January 11, 2027, provided that the Reporting Person remains a service provider through each vesting date."}],"balance_after":189361,"source":{"system":"sec-edgar","filing":"0001415889-24-027363","document":"form4-11202024_101126.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000141588924027363/form4-11202024_101126.xml","form_type":"4"}},{"id":1405082,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":63118,"kind":"person","name":"Tahir Misbah","position":1,"cik":"0001787359","reported_name":"Tahir Misbah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-09-17T20:54:47.000Z","date":"2024-09-13","kind":"sale","planned":false,"acquired":false,"shares":1487,"price":11.5388,"value":17158.1956,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $11.20 to $11.795. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":122694,"source":{"system":"sec-edgar","filing":"0001415889-24-023586","document":"form4-09182024_120944.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000141588924023586/form4-09182024_120944.xml","form_type":"4"}},{"id":1449910,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":63118,"kind":"person","name":"Tahir Misbah","position":1,"cik":"0001787359","reported_name":"Tahir Misbah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2024-07-23T20:42:45.000Z","date":"2024-07-19","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":40000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to the Issuer's previously disclosed option exchange program, on July 19, 2024 the Issuer cancelled the Reporting Person's options to purchase 55,000 shares and 40,000 shares of the Issuer's Common Stock and in exchange issued aggregate RSU grants of 33,111 shares and 2,222 shares."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Issuer's previously disclosed option exchange program, on July 19, 2024 the Issuer cancelled the Reporting Person's options to purchase 55,000 shares and 40,000 shares of the Issuer's Common Stock and in exchange issued aggregate RSU grants of 33,111 shares and 2,222 shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Issuer's previously disclosed option exchange program, on July 19, 2024 the Issuer cancelled the Reporting Person's options to purchase 55,000 shares and 40,000 shares of the Issuer's Common Stock and in exchange issued aggregate RSU grants of 33,111 shares and 2,222 shares."}],"balance_after":0,"derivative":{"exercise_price":91.5,"expiration_date":"2031-02-19","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001415889-24-020004","document":"form4-07242024_120741.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000141588924020004/form4-07242024_120741.xml","form_type":"4"}},{"id":1449909,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":63118,"kind":"person","name":"Tahir Misbah","position":1,"cik":"0001787359","reported_name":"Tahir Misbah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2024-07-23T20:42:45.000Z","date":"2024-07-19","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":55000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to the Issuer's previously disclosed option exchange program, on July 19, 2024 the Issuer cancelled the Reporting Person's options to purchase 55,000 shares and 40,000 shares of the Issuer's Common Stock and in exchange issued aggregate RSU grants of 33,111 shares and 2,222 shares."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Issuer's previously disclosed option exchange program, on July 19, 2024 the Issuer cancelled the Reporting Person's options to purchase 55,000 shares and 40,000 shares of the Issuer's Common Stock and in exchange issued aggregate RSU grants of 33,111 shares and 2,222 shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Issuer's previously disclosed option exchange program, on July 19, 2024 the Issuer cancelled the Reporting Person's options to purchase 55,000 shares and 40,000 shares of the Issuer's Common Stock and in exchange issued aggregate RSU grants of 33,111 shares and 2,222 shares."}],"balance_after":0,"derivative":{"exercise_price":40.27,"expiration_date":"2030-02-05","underlying":"Common Stock","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0001415889-24-020004","document":"form4-07242024_120741.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000141588924020004/form4-07242024_120741.xml","form_type":"4"}},{"id":1449908,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":63118,"kind":"person","name":"Tahir Misbah","position":1,"cik":"0001787359","reported_name":"Tahir Misbah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-07-23T20:42:45.000Z","date":"2024-07-19","kind":"grant","planned":false,"acquired":true,"shares":2222,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"These securities are RSUs. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. One-half of the RSUs shall vest on January 19, 2026 and one-twelfth of the RSUs shall vest each three-month anniversary thereafter, provided that the Reporting Person remains a service provider through each vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Issuer's previously disclosed option exchange program, on July 19, 2024 the Issuer cancelled the Reporting Person's options to purchase 55,000 shares and 40,000 shares of the Issuer's Common Stock and in exchange issued aggregate RSU grants of 33,111 shares and 2,222 shares."}],"balance_after":124181,"source":{"system":"sec-edgar","filing":"0001415889-24-020004","document":"form4-07242024_120741.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000141588924020004/form4-07242024_120741.xml","form_type":"4"}},{"id":1449907,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":63118,"kind":"person","name":"Tahir Misbah","position":1,"cik":"0001787359","reported_name":"Tahir Misbah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-07-23T20:42:45.000Z","date":"2024-07-19","kind":"grant","planned":false,"acquired":true,"shares":33111,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. One-half of the RSUs shall vest on July 19, 2025 and one-eighth of the RSUs shall vest each three-month anniversary thereafter, provided that the Reporting Person remains a service provider through each vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Issuer's previously disclosed option exchange program, on July 19, 2024 the Issuer cancelled the Reporting Person's options to purchase 55,000 shares and 40,000 shares of the Issuer's Common Stock and in exchange issued aggregate RSU grants of 33,111 shares and 2,222 shares."}],"balance_after":121959,"source":{"system":"sec-edgar","filing":"0001415889-24-020004","document":"form4-07242024_120741.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000141588924020004/form4-07242024_120741.xml","form_type":"4"}},{"id":1475234,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":63118,"kind":"person","name":"Tahir Misbah","position":1,"cik":"0001787359","reported_name":"Tahir Misbah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-06-18T19:43:20.000Z","date":"2024-06-14","kind":"sale","planned":false,"acquired":false,"shares":1570,"price":7.5753,"value":11893.221,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $7.26 to $7.94. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":88848,"source":{"system":"sec-edgar","filing":"0001415889-24-017499","document":"form4-06182024_110617.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000141588924017499/form4-06182024_110617.xml","form_type":"4"}},{"id":1574699,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":63118,"kind":"person","name":"Tahir Misbah","position":1,"cik":"0001787359","reported_name":"Tahir Misbah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-03-15T19:53:20.000Z","date":"2024-03-14","kind":"sale","planned":false,"acquired":false,"shares":2543,"price":10.1705,"value":25863.5815,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $9.80 to $10.43. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":90418,"source":{"system":"sec-edgar","filing":"0001415889-24-008169","document":"form4-03152024_110314.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000141588924008169/form4-03152024_110314.xml","form_type":"4"}},{"id":1574698,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":63118,"kind":"person","name":"Tahir Misbah","position":1,"cik":"0001787359","reported_name":"Tahir Misbah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-03-15T19:53:20.000Z","date":"2024-03-13","kind":"sale","planned":false,"acquired":false,"shares":2897,"price":9.8752,"value":28608.4544,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $9.625 to $10.01. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":92961,"source":{"system":"sec-edgar","filing":"0001415889-24-008169","document":"form4-03152024_110314.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000141588924008169/form4-03152024_110314.xml","form_type":"4"}},{"id":1576663,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":63118,"kind":"person","name":"Tahir Misbah","position":1,"cik":"0001787359","reported_name":"Tahir Misbah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2024-03-14T18:22:42.000Z","date":"2024-03-12","kind":"grant","planned":false,"acquired":true,"shares":92500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One forty-eighth of the shares subject to the option shall vest on April 12, 2024 and each month thereafter, provided that the Reporting Person remains a service provider through each vesting date."}],"balance_after":92500,"derivative":{"exercise_price":9.95,"expiration_date":"2034-03-12","underlying":"Common Stock","underlying_shares":92500},"source":{"system":"sec-edgar","filing":"0001415889-24-008054","document":"form4-03142024_100336.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000141588924008054/form4-03142024_100336.xml","form_type":"4"}},{"id":1576662,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":63118,"kind":"person","name":"Tahir Misbah","position":1,"cik":"0001787359","reported_name":"Tahir Misbah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-03-14T18:22:42.000Z","date":"2024-03-12","kind":"grant","planned":false,"acquired":true,"shares":46250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. One-sixteenth of the RSUs shall vest on June 12, 2024 and each three-month anniversary thereafter, provided that the Reporting Person remains a service provider through each vesting date."}],"balance_after":95858,"source":{"system":"sec-edgar","filing":"0001415889-24-008054","document":"form4-03142024_100336.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000141588924008054/form4-03142024_100336.xml","form_type":"4"}},{"id":1727630,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":63118,"kind":"person","name":"Tahir Misbah","position":1,"cik":"0001787359","reported_name":"Tahir Misbah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-11-29T20:49:40.000Z","date":"2023-11-27","kind":"sale","planned":false,"acquired":false,"shares":1337,"price":5.0592,"value":6764.1504,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $4.96 to $5.33. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":49608,"source":{"system":"sec-edgar","filing":"0001209191-23-056944","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000120919123056944/doc4.xml","form_type":"4"}},{"id":1727629,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":63118,"kind":"person","name":"Tahir Misbah","position":1,"cik":"0001787359","reported_name":"Tahir Misbah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-11-29T20:49:40.000Z","date":"2023-11-15","kind":"grant","planned":false,"acquired":true,"shares":234,"price":11.71,"value":2740.14,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were acquired under the IGM Biosciences, Inc. 2019 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":50945,"source":{"system":"sec-edgar","filing":"0001209191-23-056944","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000120919123056944/doc4.xml","form_type":"4"}},{"id":1878062,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":63118,"kind":"person","name":"Tahir Misbah","position":1,"cik":"0001787359","reported_name":"Tahir Misbah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-05-25T19:23:40.000Z","date":"2023-05-23","kind":"sale","planned":false,"acquired":false,"shares":15,"price":13.005,"value":195.075,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $13.00 to $13.02. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":50711,"source":{"system":"sec-edgar","filing":"0001209191-23-032305","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000120919123032305/doc4.xml","form_type":"4"}},{"id":1878061,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":63118,"kind":"person","name":"Tahir Misbah","position":1,"cik":"0001787359","reported_name":"Tahir Misbah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-05-25T19:23:40.000Z","date":"2023-05-23","kind":"sale","planned":false,"acquired":false,"shares":1244,"price":12.3005,"value":15301.822,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $12.00 to $12.95. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":50726,"source":{"system":"sec-edgar","filing":"0001209191-23-032305","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000120919123032305/doc4.xml","form_type":"4"}},{"id":1878060,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":63118,"kind":"person","name":"Tahir Misbah","position":1,"cik":"0001787359","reported_name":"Tahir Misbah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-05-25T19:23:40.000Z","date":"2023-05-15","kind":"grant","planned":false,"acquired":true,"shares":398,"price":11.71,"value":4660.58,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were acquired under the IGM Biosciences, Inc. 2019 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":51970,"source":{"system":"sec-edgar","filing":"0001209191-23-032305","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000120919123032305/doc4.xml","form_type":"4"}},{"id":1923718,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":63118,"kind":"person","name":"Tahir Misbah","position":1,"cik":"0001787359","reported_name":"Tahir Misbah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-04-06T21:45:45.000Z","date":"2023-04-04","kind":"grant","planned":false,"acquired":true,"shares":52500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/48 of the shares subject to the option shall vest on April 12, 2023 and each month thereafter, provided that the Reporting Person remains a service provider through each vesting date."}],"balance_after":52500,"derivative":{"exercise_price":12.86,"expiration_date":"2033-04-04","underlying":"Common Stock","underlying_shares":52500},"source":{"system":"sec-edgar","filing":"0001209191-23-023702","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000120919123023702/doc4.xml","form_type":"4"}},{"id":1923717,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":63118,"kind":"person","name":"Tahir Misbah","position":1,"cik":"0001787359","reported_name":"Tahir Misbah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-04-06T21:45:45.000Z","date":"2023-04-04","kind":"grant","planned":false,"acquired":true,"shares":26250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. One-fourth of the RSUs shall vest on March 12, 2024 and each one-year anniversary thereafter, provided that the Reporting Person remains a service provider through each vesting date."}],"balance_after":51572,"source":{"system":"sec-edgar","filing":"0001209191-23-023702","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000120919123023702/doc4.xml","form_type":"4"}},{"id":1949995,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":63118,"kind":"person","name":"Tahir Misbah","position":1,"cik":"0001787359","reported_name":"Tahir Misbah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-16T18:30:49.000Z","date":"2023-03-14","kind":"sale","acquired":false,"shares":1768,"price":18.732,"value":33118.176,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $18.34 to $19.30. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":25322,"source":{"system":"sec-edgar","filing":"0001209191-23-019420","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000120919123019420/doc4.xml","form_type":"4"}},{"id":2079767,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":63118,"kind":"person","name":"Tahir Misbah","position":1,"cik":"0001787359","reported_name":"Tahir Misbah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-12-20T20:09:10.000Z","date":"2022-12-19","kind":"sale","acquired":false,"shares":3801,"price":20,"value":76020.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."}],"balance_after":27090,"source":{"system":"sec-edgar","filing":"0001209191-22-062260","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000120919122062260/doc4.xml","form_type":"4"}},{"id":2079766,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":63118,"kind":"person","name":"Tahir Misbah","position":1,"cik":"0001787359","reported_name":"Tahir Misbah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-12-20T20:09:10.000Z","date":"2022-12-16","kind":"sale","acquired":false,"shares":815,"price":19.3595,"value":15777.9925,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $19.30 to $19.47. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":30891,"source":{"system":"sec-edgar","filing":"0001209191-22-062260","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000120919122062260/doc4.xml","form_type":"4"}},{"id":2079765,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":63118,"kind":"person","name":"Tahir Misbah","position":1,"cik":"0001787359","reported_name":"Tahir Misbah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-12-20T20:09:10.000Z","date":"2022-12-16","kind":"sale","acquired":false,"shares":1468,"price":18.7746,"value":27561.1128,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $18.29 to $19.289. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":31706,"source":{"system":"sec-edgar","filing":"0001209191-22-062260","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000120919122062260/doc4.xml","form_type":"4"}},{"id":2103357,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":63118,"kind":"person","name":"Tahir Misbah","position":1,"cik":"0001787359","reported_name":"Tahir Misbah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-11-28T20:31:03.000Z","date":"2022-11-23","kind":"sale","acquired":false,"shares":277,"price":21.9914,"value":6091.6178,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $21.74 to $22.44. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":33174,"source":{"system":"sec-edgar","filing":"0001209191-22-058912","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000120919122058912/doc4.xml","form_type":"4"}},{"id":2103356,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":63118,"kind":"person","name":"Tahir Misbah","position":1,"cik":"0001787359","reported_name":"Tahir Misbah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-11-28T20:31:03.000Z","date":"2022-11-23","kind":"sale","acquired":false,"shares":600,"price":21.3765,"value":12825.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $20.74 to $21.73. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":33451,"source":{"system":"sec-edgar","filing":"0001209191-22-058912","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000120919122058912/doc4.xml","form_type":"4"}},{"id":2103355,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":63118,"kind":"person","name":"Tahir Misbah","position":1,"cik":"0001787359","reported_name":"Tahir Misbah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-11-28T20:31:03.000Z","date":"2022-11-15","kind":"grant","acquired":true,"shares":353,"price":12.84,"value":4532.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were acquired under the IGM Biosciences, Inc. 2019 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":34051,"source":{"system":"sec-edgar","filing":"0001209191-22-058912","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000120919122058912/doc4.xml","form_type":"4"}},{"id":2255235,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":63118,"kind":"person","name":"Tahir Misbah","position":1,"cik":"0001787359","reported_name":"Tahir Misbah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-05-26T16:48:21.000Z","date":"2022-05-26","kind":"sale","acquired":false,"shares":950,"price":17.1026,"value":16247.47,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $16.8061 to $17.1269. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":33698,"source":{"system":"sec-edgar","filing":"0001209191-22-032232","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000120919122032232/doc4.xml","form_type":"4"}},{"id":2268082,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":63118,"kind":"person","name":"Tahir Misbah","position":1,"cik":"0001787359","reported_name":"Tahir Misbah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-05-17T19:00:19.000Z","date":"2022-05-13","kind":"grant","acquired":true,"shares":391,"price":12.38,"value":4840.58,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were acquired under the IGM Biosciences, Inc. 2019 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":34648,"source":{"system":"sec-edgar","filing":"0001209191-22-029859","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000120919122029859/doc4.xml","form_type":"4"}},{"id":2327366,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":63118,"kind":"person","name":"Tahir Misbah","position":1,"cik":"0001787359","reported_name":"Tahir Misbah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-03-17T18:42:17.000Z","date":"2022-03-15","kind":"grant","acquired":true,"shares":6084,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. 100% of the RSUs shall vest in December 2022, provided that the Reporting Person remains a service provider through the vesting date."}],"balance_after":34257,"source":{"system":"sec-edgar","filing":"0001209191-22-019760","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000120919122019760/doc4.xml","form_type":"4"}},{"id":2333196,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":63118,"kind":"person","name":"Tahir Misbah","position":1,"cik":"0001787359","reported_name":"Tahir Misbah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-03-15T20:54:07.000Z","date":"2022-03-12","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/48 of the shares subject to the option shall vest on April 12, 2022 and each month thereafter, provided that the Reporting Person remains a service provider through each vesting date."}],"balance_after":75000,"derivative":{"exercise_price":17.11,"expiration_date":"2032-03-12","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001209191-22-019013","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000120919122019013/doc4.xml","form_type":"4"}},{"id":2333195,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":63118,"kind":"person","name":"Tahir Misbah","position":1,"cik":"0001787359","reported_name":"Tahir Misbah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-03-15T20:54:07.000Z","date":"2022-03-12","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. One-fourth of the RSUs shall vest on March 12, 2023 and each one-year anniversary thereafter, provided that the Reporting Person remains a service provider through each vesting date."}],"balance_after":28173,"source":{"system":"sec-edgar","filing":"0001209191-22-019013","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000120919122019013/doc4.xml","form_type":"4"}},{"id":2502981,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":63118,"kind":"person","name":"Tahir Misbah","position":1,"cik":"0001787359","reported_name":"Tahir Misbah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-11-19T20:36:30.000Z","date":"2021-11-15","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. One-fourth of the RSUs will vest on each of May 23, 2022, November 22, 2022, May 22, 2023, and November 22, 2023, provided that the Reporting Person remains a service provider through each vesting date."}],"balance_after":15673,"source":{"system":"sec-edgar","filing":"0001209191-21-065986","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000120919121065986/doc4.xml","form_type":"4"}},{"id":2507286,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":63118,"kind":"person","name":"Tahir Misbah","position":1,"cik":"0001787359","reported_name":"Tahir Misbah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-11-17T18:50:35.000Z","date":"2021-11-15","kind":"grant","acquired":true,"shares":86,"price":50.99,"value":4385.14,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were acquired under the IGM Biosciences, Inc. 2019 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":5673,"source":{"system":"sec-edgar","filing":"0001209191-21-065259","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000120919121065259/doc4.xml","form_type":"4"}},{"id":2708070,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":63118,"kind":"person","name":"Tahir Misbah","position":1,"cik":"0001787359","reported_name":"Tahir Misbah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-05-18T21:42:29.000Z","date":"2021-05-14","kind":"grant","acquired":true,"shares":45,"price":45.9,"value":2065.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were acquired under the IGM Biosciences, Inc. 2019 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":5587,"source":{"system":"sec-edgar","filing":"0001209191-21-033861","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000120919121033861/doc4.xml","form_type":"4"}},{"id":2799898,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":63118,"kind":"person","name":"Tahir Misbah","position":1,"cik":"0001787359","reported_name":"Tahir Misbah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-03-09T19:18:01.000Z","date":"2021-03-05","kind":"exercise","acquired":false,"shares":2750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option, originally for 125,597 shares, of which 5,500 shares have been exercised, vested as to 1/4 of the shares on January 1, 2020, and an additional 1/48 of the shares subject to the option shall vest monthly thereafter, subject to the Reporting Person remaining a service provider through each such date."}],"balance_after":120097,"derivative":{"exercise_price":1.39,"expiration_date":"2029-01-03","underlying":"Common Stock","underlying_shares":2750},"source":{"system":"sec-edgar","filing":"0001209191-21-019267","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000120919121019267/doc4.xml","form_type":"4"}},{"id":2799897,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":63118,"kind":"person","name":"Tahir Misbah","position":1,"cik":"0001787359","reported_name":"Tahir Misbah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-03-09T19:18:01.000Z","date":"2021-03-05","kind":"exercise","acquired":true,"shares":2750,"price":1.39,"value":3822.5,"ownership":{"direct":true},"balance_after":5542,"source":{"system":"sec-edgar","filing":"0001209191-21-019267","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000120919121019267/doc4.xml","form_type":"4"}},{"id":2839282,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":63118,"kind":"person","name":"Tahir Misbah","position":1,"cik":"0001787359","reported_name":"Tahir Misbah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-02-23T21:35:21.000Z","date":"2021-02-19","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48 of the shares subject to the option shall vest each month following February 19, 2021 on the same day of the month, subject to Reporting Person remaining a service provider through each such date."}],"balance_after":40000,"derivative":{"exercise_price":91.5,"expiration_date":"2031-02-19","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-21-013593","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000120919121013593/doc4.xml","form_type":"4"}},{"id":2934638,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":63118,"kind":"person","name":"Tahir Misbah","position":1,"cik":"0001787359","reported_name":"Tahir Misbah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-12-22T16:43:39.000Z","date":"2020-12-21","kind":"exercise","acquired":false,"shares":2750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option, originally for 125,597 shares, of which 2,750 shares have been exercised, vested as to 1/4 of the shares on January 1, 2020, and an additional 1/48 of the shares subject to the option shall vest monthly thereafter, subject to the Reporting Person remaining a service provider through each such date."}],"balance_after":122847,"derivative":{"exercise_price":1.39,"expiration_date":"2029-01-03","underlying":"Common Stock","underlying_shares":2750},"source":{"system":"sec-edgar","filing":"0001209191-20-064850","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000120919120064850/doc4.xml","form_type":"4"}},{"id":2934637,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":63118,"kind":"person","name":"Tahir Misbah","position":1,"cik":"0001787359","reported_name":"Tahir Misbah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-12-22T16:43:39.000Z","date":"2020-12-21","kind":"exercise","acquired":true,"shares":2750,"price":1.39,"value":3822.5,"ownership":{"direct":true},"balance_after":2792,"source":{"system":"sec-edgar","filing":"0001209191-20-064850","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000120919120064850/doc4.xml","form_type":"4"}},{"id":2977551,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":63118,"kind":"person","name":"Tahir Misbah","position":1,"cik":"0001787359","reported_name":"Tahir Misbah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-11-17T20:51:09.000Z","date":"2020-11-13","kind":"grant","acquired":true,"shares":42,"price":45.45,"value":1908.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were acquired under the IGM Biosciences, Inc. 2019 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":42,"source":{"system":"sec-edgar","filing":"0001209191-20-058934","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000120919120058934/doc4.xml","form_type":"4"}},{"id":3284487,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":63118,"kind":"person","name":"Tahir Misbah","position":1,"cik":"0001787359","reported_name":"Tahir Misbah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-02-07T17:50:14.000Z","date":"2020-02-05","kind":"grant","acquired":true,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48 of the shares subject to the option shall vest each month following February 5, 2020 on the same day of the month subject to Reporting Person remaining a service provider through each such date."}],"balance_after":55000,"derivative":{"exercise_price":40.27,"expiration_date":"2030-02-05","underlying":"Common Stock","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0001209191-20-007632","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000120919120007632/doc4.xml","form_type":"4"}}]}